Related references
Note: Only part of the references are listed.Repositioning itraconazole for amelioration of bleomycin-induced pulmonary fibrosis: Targeting HMGB1/TLR4 Axis, NLRP3 inflammasome/NF-κB signaling, and autophagy
Abeer Elkhoely et al.
LIFE SCIENCES (2023)
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation
Guangrui Chen et al.
MOLECULES (2023)
Mirtazepine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
Rasha Abdelhady et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
NLRP3 Inflammasome: A key contributor to the inflammation formation
Wen-Juan Zhang et al.
FOOD AND CHEMICAL TOXICOLOGY (2023)
Diallyl trisulfide inhibits monosodium urate-induced NLRP3 inflammasome activation via NOX3/4-dependent mitochondrial oxidative stress in RAW 264.7 and bone marrow-derived macrophages
Min Yeong Kim et al.
PHYTOMEDICINE (2023)
The Role of Lung Resident Mesenchymal Stromal Cells in the Pathogenesis and Repair of Chronic Lung Disease
Declan F. Doherty et al.
STEM CELLS (2023)
Geniposide improves bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and modulating metabolism
Yi Wei et al.
Journal of Functional Foods (2023)
Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
Li-Li Ren et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2023)
VX-765 attenuates silica-induced lung inflammatory injury and fibrosis by modulating alveolar macrophages pyroptosis in mice
Huihui Tao et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2023)
Mechanisms of NLRP3 inflammasome- mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis
Harsh Vardhan Charan et al.
GENES & DISEASES (2023)
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Benjamin J. Moss et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
Qianru Mei et al.
FRONTIERS IN PHARMACOLOGY (2022)
Nanoformulation of a carbon monoxide releasing molecule protects against cyclosporin A-induced nephrotoxicity and renal fibrosis via the suppression of the NLRP3 inflammasome mediated TGF-β/Smad pathway
Zhengmei Xia et al.
ACTA BIOMATERIALIA (2022)
The Inflammasome NLR Family Pyrin Domain-Containing Protein 3 (NLRP3) as a Novel Therapeutic Target for Idiopathic Pulmonary Fibrosis
Ruben M. L. Colunga Biancatelli et al.
AMERICAN JOURNAL OF PATHOLOGY (2022)
Galectin-3 regulates microglial activation and promotes inflammation through TLR4/MyD88/NF-kB in experimental autoimmune uveitis
Yusen Liu et al.
CLINICAL IMMUNOLOGY (2022)
Targeting TGF-β signal transduction for fibrosis and cancer therapy
Dandan Peng et al.
MOLECULAR CANCER (2022)
Activation of NLRP3 inflammasome in stable chronic obstructive pulmonary disease
Ivona Markelic et al.
SCIENTIFIC REPORTS (2022)
L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis
Hemant Joshi et al.
CELL REPORTS (2022)
ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation
Dongxin Chen et al.
FRONTIERS IN PHARMACOLOGY (2022)
The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
Carol M. Artlett
BIOMOLECULES (2022)
Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?
Elena Ortiz-Zapater et al.
BIOMEDICINES (2022)
Deciphering the role of damage-associated molecular patterns and inflammatory responses in acute lung injury
Po-Chun Hsieh et al.
LIFE SCIENCES (2022)
Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary Fibrosis
Weiwei Zhu et al.
LUNG (2022)
Activation and regulation mechanisms of NOD-like receptors based on structural biology
Umeharu Ohto
FRONTIERS IN IMMUNOLOGY (2022)
Transcriptional inhibition of miR-486-3p by BCL6 upregulates Snail and induces epithelial-mesenchymal transition during radiation-induced pulmonary fibrosis
Ziyan Yan et al.
RESPIRATORY RESEARCH (2022)
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
Susanne Gaul et al.
JOURNAL OF HEPATOLOGY (2021)
Astragaloside IV alleviates silica-induced pulmonary fibrosis via inactivation of the TGF-β1/Smad2/3 signaling pathway
Nannan Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
NOD-like receptors in autoimmune diseases
Li Chen et al.
ACTA PHARMACOLOGICA SINICA (2021)
Snail-mediated partial epithelial mesenchymal transition augments the differentiation of local lung myofibroblast
Yan Wang et al.
CHEMOSPHERE (2021)
Interleukin-18 in Inflammatory Kidney Disease
Yasuaki Hirooka et al.
FRONTIERS IN MEDICINE (2021)
NLRP3 inflammasome activation in alveolar epithelial cells promotes myofibroblast differentiation of lung-resident mesenchymal stem cells during pulmonary fibrogenesis
Jie Ji et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
The inflammatory speech of fibroblasts
Ronen Schuster et al.
IMMUNOLOGICAL REVIEWS (2021)
TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review)
Zhimin Ye et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
Pyroptosis: Mechanisms and Links with Fibrosis
Zihao Song et al.
CELLS (2021)
Toll-like receptor 4: An attractive therapeutic target for acute kidney injury
Ankush Kumar Jha et al.
LIFE SCIENCES (2021)
Resistin induces cardiac fibroblast-myofibroblast differentiation through JAK/STAT3 and JNK/c-Jun signaling
Rajvir Singh et al.
PHARMACOLOGICAL RESEARCH (2021)
Andrographolide alleviates bleomycin-induced NLRP3 inflammasome activation and epithelial-mesenchymal transition in lung epithelial cells by suppressing AKT/mTOR signaling pathway
Jingpei Li et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Targeting the gasdermin D as a strategy for ischemic stroke therapy
Jiabing Wang et al.
BIOCHEMICAL PHARMACOLOGY (2021)
NLRP3 inflammasome activation and cell death
Yi Huang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Danggui Buxue Tang Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing the TLR4/NLRP3 Signaling Pathway in Rats
Jiepeng Wang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)
Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats
Yongcan Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways
Yue Xiong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Paula Montero et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of the inflammasome, gasdermin D, and pyroptosis in non-alcoholic fatty liver disease
Itzayana Rodriguez-Antonio et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
Yu Nakanishi et al.
PLOS ONE (2021)
Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidence
Megan Vierhout et al.
WOUND REPAIR AND REGENERATION (2021)
Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma
Ming Ma et al.
FRONTIERS IN IMMUNOLOGY (2021)
Inflammasomes and Fibrosis
Wen-Juan Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
The bright side of fibroblasts: molecular signature and regenerative cues in major organs
Rita N. Gomes et al.
NPJ REGENERATIVE MEDICINE (2021)
Pattern recognition receptors in health and diseases
Danyang Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
Jin Kyung Seok et al.
ARCHIVES OF PHARMACAL RESEARCH (2021)
Alveolar and lung interstitial macrophages: Definitions, functions, and roles in lung fibrosis
Ting Shi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders
Wai Chin Chong et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
Molecular mechanism of myofibroblast formation and strategies for clinical drugs treatments in hypertrophic scars
Ziying Zhu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis
Chang-Mei Weng et al.
BIOSCIENCE REPORTS (2020)
Carbon black nanoparticles induce pulmonary fibrosis through NLRP3 inflammasome pathway modulated by miR-96 targeted FOXO3a
Lixiao Zhou et al.
CHEMOSPHERE (2020)
CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway
Yang Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Boris Hinz et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Contribution of TGF-Beta-Mediated NLRP3-HMGB1 Activation to Tubulointerstitial Fibrosis in Rat With Angiotensin II-Induced Chronic Kidney Disease
Kaimin Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Pericyte-myofibroblast transition in the human lung
Miki Yamaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
Amani Abraheem Alsadiq Alyaseer et al.
FRONTIERS IN IMMUNOLOGY (2020)
Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways
Qun Lv et al.
MOLECULAR MEDICINE (2020)
Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis
Qing Liang et al.
PHARMACOLOGICAL RESEARCH (2020)
Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway
Xuewu Zhang et al.
IMMUNITY (2020)
Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis
Archana Vijay Gaikwad et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Danping Zheng et al.
CELL DISCOVERY (2020)
Antiviral activity of lycorine against Zika virus in vivo and in vitro
Huini Chen et al.
VIROLOGY (2020)
Ligustilide modulates oxidative stress, apoptosis, and immunity to avoid pathological damages in bleomycin induced pulmonary fibrosis rats via inactivating TLR4/MyD88/NF-KB P65
Shu Luo et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by the Inhibition of TGF-beta 1/Smad3 and PI3K/AKT/mTOR Pathways
Hanaa Wanas et al.
CURRENT MOLECULAR PHARMACOLOGY (2020)
Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation
Ling Peng et al.
CELL DEATH & DISEASE (2020)
NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways
Jaye M. Platnich et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation
Rhiannon Campden et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer
Fernando J. Velloso et al.
BIOSCIENCE REPORTS (2019)
The Hsp27-Mediated IkBα-NFκB Signaling Axis Promotes Radiation-Induced Lung Fibrosis
Jee-Youn Kim et al.
CLINICAL CANCER RESEARCH (2019)
Diverse Pharmacological Activities and Potential Medicinal Benefits of Geniposide
Yan-Xi Zhou et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies
Peng Liu et al.
PHYTOMEDICINE (2019)
MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
Gulcin Tezcan et al.
FRONTIERS IN PHARMACOLOGY (2019)
Structure, interactions and self-assembly of ASC-dependent inflammasomes
Eva de Alba
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway
Hongzhi Hu et al.
ONCOTARGETS AND THERAPY (2019)
Structural Basis of IL-1 Family Cytokine Signaling
James K. Fields et al.
FRONTIERS IN IMMUNOLOGY (2019)
CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
Roberto S. Accolla et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
Christian Bailly
PHYTOMEDICINE (2019)
Raltegravir Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo
Xue Zhang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Fibrocytes and fibroblasts-Where are we now
Sy Giin Chong et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition
Li-Ming Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Intestinal fibrosis
Marco Vincenzo Lenti et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells
Chuyi Zhang et al.
RESPIRATORY RESEARCH (2019)
A pathologic two-way street: how innate immunity impacts lung fibrosis and fibrosis impacts lung immunity
Helen Warheit-Niemi et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Interleukin-18: Biological properties and role in disease pathogenesis
Gilles Kaplanski
IMMUNOLOGICAL REVIEWS (2018)
The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication
Pardis Pakshir et al.
MATRIX BIOLOGY (2018)
Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation
Yi Li et al.
MOLECULAR IMMUNOLOGY (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis
Karim C. El Kasmi et al.
NATURE COMMUNICATIONS (2018)
Extracellular ATP is a danger signal activating P2X7 Receptor in a LPS mediated inflammation (ARDS/ALI)
Sanja Cicko et al.
Oncotarget (2018)
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
Sun Young Kyung et al.
BMC PHARMACOLOGY & TOXICOLOGY (2018)
TGF-β receptors: In and beyond TGF-β signaling
Alexandra Vander Ark et al.
CELLULAR SIGNALLING (2018)
NLRP3 inflammasome activation and lung fibrosis caused by airborne fine particulate matter
Runxiao Zheng et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2018)
NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway
Iva Hafner-Bratkovic et al.
NATURE COMMUNICATIONS (2018)
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Omkar Desai et al.
FRONTIERS IN MEDICINE (2018)
Purinergic receptors: new targets for the treatment of gout and fibrosis
Thomas Gicquel et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis
Rui Tian et al.
EXPERIMENTAL CELL RESEARCH (2017)
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Jianjin Shi et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Gasdermins: Effectors of Pyroptosis
Stephen B. Kovacs et al.
TRENDS IN CELL BIOLOGY (2017)
Astragaloside IV Improves Bleomycin-Induced Pulmonary Fibrosis in Rats by Attenuating Extracellular Matrix Deposition
Liu-Cheng Li et al.
FRONTIERS IN PHARMACOLOGY (2017)
Idiopathic pulmonary fibrosis
Fernando J. Martinez et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Salidroside Attenuates Ventilation Induced Lung Injury via SIRT1-Dependent Inhibition of NLRP3 Inflammasome
Yan Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases
Mutlay Sayan et al.
PARTICLE AND FIBRE TOXICOLOGY (2016)
CITA/NLRC5: A critical transcriptional regulator of MHC class I gene expression
Isaac Downs et al.
BIOFACTORS (2016)
The killer protein Gasdermin D
John A. Wright et al.
CELL DEATH AND DIFFERENTIATION (2016)
Interleukin-18 deficiency protects against renal interstitial fibrosis in aldosterone/salt-treated mice
Akiko Tanino et al.
CLINICAL SCIENCE (2016)
Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1/IL-1R1/MyD88/NF-B pathway
Cheng Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin
Olivier Burgy et al.
RESPIRATORY RESEARCH (2016)
Analysis of blood neutrophil elastase, glutathione levels and pathological findings in postoperative acute exacerbation of idiopathic pulmonary fibrosis associated with lung cancer: Two case reports
Keishi Sugino et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers
Jos L. J. van der Velden et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2016)
NOD-LIKE RECEPTORS: VERSATILE CYTOSOLIC SENTINELS
Vinicius Motta et al.
PHYSIOLOGICAL REVIEWS (2015)
NLRP3 inflammasome and its inhibitors: a review
Bo-Zong Shao et al.
FRONTIERS IN PHARMACOLOGY (2015)
Mechanisms and Functions of Inflammasomes
Mohamed Lamkanfi et al.
CELL (2014)
Elevated expression of the NLRP3 inflammasome in neutrophilic asthma
Jodie L. Simpson et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes
Prajwal Gurung et al.
JOURNAL OF IMMUNOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Activation of NLRP3 inflammasome by crystalline structures via cell surface contact
Aswin Hari et al.
SCIENTIFIC REPORTS (2014)
Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation and fibrosis in C57BL/6 mice
Jiali Guo et al.
ARCHIVES OF TOXICOLOGY (2013)
NLRC5, at the heart of antigen presentation
Andreas Neerincx et al.
FRONTIERS IN IMMUNOLOGY (2013)
Functions of NOD-like receptors in human diseases
Yifei Zhong et al.
FRONTIERS IN IMMUNOLOGY (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
MEK-ERK Pathway Modulation Ameliorates Pulmonary Fibrosis Associated with Epidermal Growth Factor Receptor Activation
Satish K. Madala et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Immunology in clinic review series; focus on autoinflammatory diseases: inflammasomes: mechanisms of activation
A. K. Mankan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
Akihiro Takemasa et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Activation of the NLRP3 Inflammasome by Group B Streptococci
Alessandro Costa et al.
JOURNAL OF IMMUNOLOGY (2012)
NLRC5: a key regulator of MHC class I-dependent immune responses
Koichi S. Kobayashi et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Leucine-rich repeat (LRR) proteins Integrators of pattern recognition and signaling in immunity
Aylwin Ng et al.
AUTOPHAGY (2011)
Understanding the mechanism of IL-1β secretion
Gloria Lopez-Castejon et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Sensing damage by the NLRP3 inflammasome
Jaklien C. Leemans et al.
IMMUNOLOGICAL REVIEWS (2011)
Extracellular ATP Is a Danger Signal Activating P2X7 Receptor in Lung Inflammation and Fibrosis
Nicolas Riteau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
Thomas H. Sisson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Nod proteins link bacterial sensing and autophagy
Leonardo H. Travassos et al.
AUTOPHAGY (2010)
ATP and the pathogenesis of COPD
Esmaeil Mortaz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9
Jamshid Davoodi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Disruption of Interleukin-1 Signaling Improves the Quality of Wound Healing
Alan A. Thomay et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis
Pamela Gasse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Role of Proinflammatory Cytokines IL-18 and IL-1β in Bleomycin-Induced Lung Injury in Humans and Mice
Tomoaki Hoshino et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Function of Nod-like receptors in microbial recognition and host defense
Luigi Franchi et al.
IMMUNOLOGICAL REVIEWS (2009)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-1R1/MyD88 Signaling Is Critical for Elastase-Induced Lung Inflammation and Emphysema
Isabelle Couillin et al.
JOURNAL OF IMMUNOLOGY (2009)
Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling
Dong Dong Luo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis
A. Jayachandran et al.
THORAX (2009)
Putting the kibosh on mitochondrial antiviral signaling
Robert P. Kruger
CELL (2008)
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Alessandro Sorrentino et al.
NATURE CELL BIOLOGY (2008)
The Nod-Like Receptor (NLR) Family: A Tale of Similarities and Differences
Martina Proell et al.
PLOS ONE (2008)
NLRX1 is a regulator of mitochondrial antiviral immunity
Chris B. Moore et al.
NATURE (2008)
IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice
Pamela Gasse et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
Matt K. Lee et al.
EMBO JOURNAL (2007)
Therapies for bleomycin induced lung fibrosis through regulation of TGF-β1 induced collagen gene expression
Kenneth R. Cutroneo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling
Joseph A. Duncan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis
Felix Chua et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Unraveling signalling cascades for the Snail family of transcription factors
B De Craene et al.
CELLULAR SIGNALLING (2005)
Interleukin-1β causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung
U Lappalainen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis
Y Kitasato et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase-1
YT Wang et al.
INTERNATIONAL IMMUNOLOGY (2004)
MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis
K Yoshida et al.
JOURNAL OF PATHOLOGY (2002)
IAP suppression of apoptosis involves distinct mechanisms: The TAK1/JNK1 signaling cascade and caspase inhibition
MG Sanna et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)